12:00 AM
Apr 15, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

StemCells completes debt financing

StemCells Inc. (NASDAQ:STEM), Newark, Calif.
Business: Gene/Cell therapy, Neurology
Date completed: 4/3/13

Read the full 45 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >